Fig. 3
Forest plot comparing ICS-L vs. placebo for moderate or severe asthma exacerbations. Visual assessment indicates low heterogeneity, similar point estimates, overlapped CI, and I2 = 0 [12]. Zhao Y, et al. Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis. The Journal of asthma: official journal of the Association for the Care of Asthma. 2015, reprinted by permission of the publisher (Taylor & Francis Ltd., WWW.tandfonline.com) [12]